{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:54:07Z","timestamp":1756191247780,"version":"3.32.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,24]]},"DOI":"10.7759\/cureus.76299","type":"journal-article","created":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T10:36:26Z","timestamp":1735036586000},"source":"Crossref","is-referenced-by-count":1,"title":["Sickle Cell Disease: A Potential Cause of Immune Thrombocytopenia"],"prefix":"10.7759","author":[{"given":"Abdulwahab Ahmed A","family":"Alkhars","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed A","family":"Alkadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussain M","family":"Alwabari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagshak","family":"Mandong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahraa Y","family":"Almakinah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.18109","article-title":"Autoimmune disease and sickle cell anaemia: 'intersecting pathways and differential diagnosis'","volume":"197","author":"Piccin A","year":"2022","unstructured":"Piccin A, O'Connor-Byrne N, Daves M, Lynch K, Farshbaf AD, Martin-Loeches I. Autoimmune disease and sickle cell anaemia: 'intersecting pathways and differential diagnosis'. Br J Haematol. 2022, 197:518-28. 10.1111\/bjh.18109","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20727","article-title":"Acute splenic sequestration crisis in adults with sickle cell anemia","volume":"82","author":"Koduri PR","year":"2007","unstructured":"Koduri PR. Acute splenic sequestration crisis in adults with sickle cell anemia. Am J Hematol. 2007, 82:174-5. 10.1002\/ajh.20727","journal-title":"Am J Hematol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/adc.62.6.585","article-title":"Parvovirus associated aplastic crisis in homozygous sickle cell disease","volume":"62","author":"Goldstein AR","year":"1987","unstructured":"Goldstein AR, Anderson MJ, Serjeant GR. Parvovirus associated aplastic crisis in homozygous sickle cell disease. Arch Dis Child. 1987, 62:585-8. 10.1136\/adc.62.6.585","journal-title":"Arch Dis Child"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24255","article-title":"Effects of hydroxyurea treatment for patients with hemoglobin SC disease","volume":"91","author":"Luchtman-Jones L","year":"2016","unstructured":"Luchtman-Jones L, Pressel S, Hilliard L, et al.. Effects of hydroxyurea treatment for patients with hemoglobin SC disease. Am J Hematol. 2016, 91:238-42. 10.1002\/ajh.24255","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.17204","article-title":"Monocytes as potential therapeutic sensors in glucocorticoid-treated newly diagnosed immune thrombocytopenia","volume":"192","author":"Kapur R","year":"2021","unstructured":"Kapur R. Monocytes as potential therapeutic sensors in glucocorticoid-treated newly diagnosed immune thrombocytopenia. Br J Haematol. 2021, 192:233-4. 10.1111\/bjh.17204","journal-title":"Br J Haematol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American Society of Hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert C","year":"2019","unstructured":"Neunert C, Terrell DR, Arnold DM, et al.. American Society of Hematology 2019 guidelines for immune thrombocytopenia. Blood Adv. 2019, 3:3829-66. 10.1182\/bloodadvances.2019000966","journal-title":"Blood Adv"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines DB","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002, 346:995-1008. 10.1056\/NEJMra010501","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2023.284552","article-title":"Prevalence of autoimmune diseases in patients with sickle cell disease: a single center retrospective analysis","volume":"109","author":"Tang MW","year":"2024","unstructured":"Tang MW, Nur E, Van Tuijn CF, Biemond BJ. Prevalence of autoimmune diseases in patients with sickle cell disease: a single center retrospective analysis. Haematologica. 2024, 109:3735-8. 10.3324\/haematol.2023.284552","journal-title":"Haematologica"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0027-9684(15)31410-3","article-title":"Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease","volume":"100","author":"Darbari DS","year":"2008","unstructured":"Darbari DS, Fasano RS, Minniti CP, Castro OO, Gordeuk VR, Taylor JG 6th, Rehm JY. Severe vaso-occlusive episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J Natl Med Assoc. 2008, 100:948-51. 10.1016\/S0027-9684(15)31410-3","journal-title":"J Natl Med Assoc"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.285445","article-title":"Sickle cell and autoimmune disease: a double whammy","volume":"109","author":"De Kreuk AM","year":"2024","unstructured":"De Kreuk AM. Sickle cell and autoimmune disease: a double whammy. Haematologica. 2024, 109:3471-3. 10.3324\/haematol.2024.285445","journal-title":"Haematologica"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2021-148387","article-title":"Higher prevalence of autoimmune diseases in patients with sickle cell disease","volume":"138","author":"Tang MW","year":"2021","unstructured":"Tang MW, Nur E, Van Tuijn CFJ, Biemond BJ. Higher prevalence of autoimmune diseases in patients with sickle cell disease. Blood. 2021, 138:982. 10.1182\/blood-2021-148387","journal-title":"Blood"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326732-sickle-cell-disease-a-potential-cause-of-immune-thrombocytopenia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,24]],"date-time":"2024-12-24T10:36:27Z","timestamp":1735036587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326732-sickle-cell-disease-a-potential-cause-of-immune-thrombocytopenia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,24]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.76299","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,24]]}}}